EVFM Evofem Biosciences Inc

Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.

$0.07
As of 12/02/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/20/2014
Outstanding shares:  189,961,346
Average volume:  3,362,697
Market cap:   $5,150,157
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%